Jun-Sub Kim
Research Subjects
Research Interests
Jun-Sub Kim has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hyun Woo Cho1 shared publication
- Jong Hyun Nho
Senior Researcher, Korean Medicine Non-clinical Study Center, National Institute for Korean Medicine Development
1 shared publication - Kyeong Wan Woo1 shared publication
- Su-Yeong Kim
Assistant Researcher, Korean Medicine Non-clinical Study Center, National Institute for Korean Medicine Development
1 shared publication - Sung-Min Hwang
Researcher, Korean Medicine Non-clinical Study Center, National Institute for Korean Medicine Development
1 shared publication - Sung-Young Jo
Assistant Researcher, Korean Medicine Non-clinical Study Center, National Institute for Korean Medicine Development
1 shared publication
Latest Publications
- Open Access
- 1 September 2024
- Published by The Society of Korean Medicine in Journal of Korean Medicine
- Vol. 45 (3) , 40-53
Acute toxicity and genotoxicity assessment of Ligigeopoong-san
Objectives: This study aimed to investigate whether Ligigeopoong-san induces acute toxicity and genotoxicityMethods: Ligigeopoong-san contains the rhizome of Cnidium officinale MAKINO, an herb with potential teratogenicity. Teratogenicity is closely associated with genotoxicity. We analyzed whether Ligigeopoong-san induces acute toxicity and genotoxicity using various experimental models in accordance with Korean non-clinical test standards for pharmaceuticals and OECD test guidelines.Results : When Ligigeopoong-san was administered as a single dose to male and female rats, no toxic reactions, including organ damage, were observed at doses up to 2,500 mg/kg. In the bacterial reverse mutation test, no DNA mutations were detected at concentrations up to 5,000 μg/plate. In cell models, Ligigeopoong-san did not induce structural or numerical chromosomal aberrations at concentrations up to 2,000 μg/mL. Additionally, in animal studies, it did not cause bone marrow toxicity or form micronuclei in erythrocytes at doses up to 2,000 mg/kg.Conclusions : The experiments using various models demonstrated that Ligigeopoong-san did not induce acute toxicity or genotoxicity.
- 1 September 2024
- Published by The Society of Korean Medicine in Journal of Korean Medicine
- Vol. 45 (3) , 40-53
Open AccessAcute toxicity and genotoxicity assessment of Ligigeopoong-san
Objectives: This study aimed to investigate whether Ligigeopoong-san induces acute toxicity and genotoxicityMethods: Ligigeopoong-san contains the rhizome of Cnidium officinale MAKINO, an herb with potential teratogenicity. Teratogenicity is closely associated with genotoxicity. We analyzed whether Ligigeopoong-san induces acute toxicity and genotoxicity using various experimental models in accordance with Korean non-clinical test standards for pharmaceuticals and OECD test guidelines.Results : When Ligigeopoong-san was administered as a single dose to male and female rats, no toxic reactions, including organ damage, were observed at doses up to 2,500 mg/kg. In the bacterial reverse mutation test, no DNA mutations were detected at concentrations up to 5,000 μg/plate. In cell models, Ligigeopoong-san did not induce structural or numerical chromosomal aberrations at concentrations up to 2,000 μg/mL. Additionally, in animal studies, it did not cause bone marrow toxicity or form micronuclei in erythrocytes at doses up to 2,000 mg/kg.Conclusions : The experiments using various models demonstrated that Ligigeopoong-san did not induce acute toxicity or genotoxicity.